About NCCC
Donate Now
Press Center
Jobs
Newsletter SignUp
Get updates on the latest NCCC research findings and programs.
View Newsletters
Resources For:  

Kaposi's sarcoma and non-Hodgkin lymphoma (NHL) in San Francisco


Kaposi's sarcoma and non-Hodgkin lymphoma (NHL) in San Francisco

This communication to the journal AIDS discusses trends in the incidence of two HIV-related cancers, Kaposi's sarcoma (KS) and non-Hodgkin lymphoma (NHL), in the young adult male population of San Francisco county. Incidence rates of both KS and NHL increased sharply in this population in the mid 1980s subsequent to the spread of HIV and AIDS. Rates of both cancers peaked in the early 1990s, and have declined sharply in the late 1990s. These recent decreases are thought to be attributable to the introduction of effective HIV combination therapies. As of 1998, rates of both KS and NHL had declined to levels similar to those at the beginning of the HIV epidemic, and rates of NHL exceeded those of KS, making NHL the most common HIV-associated cancer in this population.

NCCC Principal Investigator: Christina Clarke, Ph.D.

Funding Source: Surveillance, Epidemiology, and End Results (SEER) Program

Publication: Clarke CA. Changing incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma among young men in San Francisco. AIDS 2001; 15(14):1913-5.

Back to Top
 

Fremont Bank Foundation

Northern California Cancer Center gratefully thanks and acknowledges the Fremont Bank Foundation for its sponsorship of our website.